BenchSci Comparables
Find the most relevant public market comparables for BenchSci, including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
BenchSci develops ASCEND, an AI-powered platform that helps scientists accelerate drug discovery and improve patient outcomes by providing an unmatched understanding of disease biology. It uses machine learning and artificial intelligence to translate both closed and open-access data into recommendations for specific experiments, enabling researchers to run successful experiments faster and more efficiently.
Business Model
Software as a Service (SaaS) providing an AI-driven platform for drug discovery research.
Target Customers
Pharmaceutical companies, research institutions, and scientists involved in preclinical drug discovery.
Specific Focus
AI-powered drug discovery platform focusing on preclinical research and reagent selection.
Location
Toronto, Ontario
CEO
Liran Belenzon
Industry
Life sciences
Sub Sector
Biotechnology, Pharmaceutical Research
3yr Revenue Growth
743%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to BenchSci in the Life Sciences sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for BenchSci? Our platform provides detailed analysis of BenchSci's competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full BenchSci compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full BenchSci Compset
As a leading player in the Life sciences industry within the Life Sciences sector, BenchSci operates in the specialized Biotechnology, Pharmaceutical Research sub-sector. Understanding how BenchSci compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology, Pharmaceutical Research space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of BenchSci and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free